Royalty Pharma plc
- RPRX
- NASDAQ
- Medical - Pharmaceuticals
- Biopharma Royalty Funding
- Royalty Acquisition/Investing
$60.96
Today +2.25%Quote Oct 16, 2026, 08:00 PM UTC
+3.44%over the last month
Max drawdown −4.6%From 1-month high 0.0%3 months +6.4%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$27.14B
Quote Oct 16
Next earnings
Nov 4
Expected, not confirmed
Analyst target
$63.33
+3.9% from here
Floor
$59.86
1.8% below price
Where the price sits
11 analysts
Analyst range, low to high
$57.00$67.00
- Price $60.96
- Resistance $61.98–$62.61
- Consensus $63.33
The price is just above its floor and right under resistance. Analysts' average target sits about 4% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about RPRXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
Q2 2026 revenue $674.1M
- Financial Royalty Assets$638.0M94.6%
- Royalty Income, Other$36.1M5.4%
Industry
Medical - Pharmaceuticals
Employees
100
Founded
1996